Chemomab Therapeutics: Q2 Earnings Insights
Chemomab Therapeutics: Q2 Earnings Insights
Chemomab Therapeutics (NASDAQ:CMMB) reported its Q2 earnings results on Friday, August 12, 2022 at 06:00 AM.
Chemomab治疗学纳斯达克(Sequoia Capital：CMMB)于2022年8月12日(星期五)上午06：00公布第二季度收益业绩。
Here's what investors need to know about the announcement.
以下是投资者需要知道的关于这一声明的信息。
Earnings
收益
Chemomab Therapeutics missed estimated earnings by 116.0%, reporting an EPS of $-0.54 versus an estimate of $-0.25.
Chemomab治疗公司的预期收益低于预期的116.0%，每股收益为-0.54美元，而预期为-0.25美元。
Revenue was down $0 from the same period last year.
营收比去年同期下降了0美元。
Past Earnings Performance
过去的盈利表现
Last quarter the company beat on EPS by $0.22 which was followed by a 8.14% increase in the share price the next day.
上个季度，该公司每股收益高出0.22美元，第二天股价上涨了8.14%。
To track all earnings releases for Chemomab Therapeutics visit their earnings calendar here.
要跟踪Chemomab治疗公司的所有收益发布，请访问此处的收益日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。